Fenofibrate Tablet, Coated
Product Images NDC 65862-769

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 65862-769). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (48 mg (90 Tablet Bottle))

FDA Label Image

Package Label-principal Display Panel (48 mg Blister Carton (10 x 10 Unit-dose))

Package Label-principal Display Panel (48 mg Blister Carton (10 x 10 Unit-dose))
This is the package insert for Fenofibrate Tablets USP manufactured by Aurobindo Pharma USA Inc. Each film-coated tablet contains 48mg of fenofibrate and is intended for prescription use only. The recommended dosage is provided within the package insert. The tablets should be stored in a USP tight container at a temperature of 20 to 25°C, with protection from moisture. This drug is distributed by Aurobindo Pharma USA Inc. in East Windsor, NJ and is made in India.*
FDA Label Image

Package Label-principal Display Panel (145 mg (90 Tablet Bottle))

Package Label-principal Display Panel (145 mg (90 Tablet Bottle))
This is a description of a medication called Fenofibrate USP in a film-coated tablet format with a concentration of 145mg. It is distributed by Aurohindo Pharma USA, Inc. and its National Drug Code is 65862-769-90. The recommended dosage is noted to be found in the package insert. It should be stored at an ideal temperature range of 20°C to 25°C (68°F to 77°F) and protected from moisture. The medication's seal over the bottle opening should be intact before accepting. It is intended for use with a tight container, and its associated code is TS/DRUGS/22/2009. *
FDA Label Image

Package Label-principal Display Panel (145 mg Blister Carton (10 x 10 Unit-dose))

Package Label-principal Display Panel (145 mg Blister Carton (10 x 10 Unit-dose))
This is a medication called Fenofibrate, which is used in the treatment of high cholesterol and triglyceride levels. It comes in the form of film-coated tablets containing 145mg of Fenofibrate per tablet. The usual dosage and prescribing information can be found in the package insert. The medication should be stored in a tightly closed container and protected from moisture, at controlled room temperature. This medication is distributed by Aurobindo Pharma USA Inc. and Made in India.*
FDA Label Image

Chemical Structure (Fenofibrate Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.